 |
Dr Cécile Aubron PhD
Adjunct Senior Research Fellow
Email
Dr Cécile Aubron is a French intensive care physician who was the ANZIC-RC's Senior Research Fellow in 2010. During that time she was actively involved in the ANZIC-RC's "Age of Blood" research project including the feasibility pilot study in preparation for the large randomised controlled trial (RCT) and the publishing of the pilot study. Dr Aubron is now an Associate Investigator on the ANZIC-RC's recently successful $2.7m NHMRC grant, STandaRd Issue TrANsfusion versuS Fresher red blood cell Use in intenSive carE (TRANSFUSE) RCT. In 2011 she was the co-recipient of The Alfred ICU - Monash University Research Fellowship. She is currently an Intensivist at Austin Hospital. Dr Aubron originally trained in Paris, France, and her qualifications include a Master's degree in Microbiology; an MD; and a PhD entitled "Study of the Escherichia coli metabolic polymorphism, involvement in adaptation and virulence". Dr Aubron has published 7 book chapters and 20 papers in international refereed journals on topics such as blood, infectious diseases, including pandemic (H1N1 (2009) influenza epidemic) research, and pharmacokinetic modeling research. She has delivered conference presentations in France, Senegal and Australia.
 |
Professor Gilles Capellier MD MSc PhD
Adjunct Professor
Professor Capellier is an Adjunct Professor with the ANZIC-RC. He was a Visitor at the ANZIC-RC for one year (2011-2012) when he was on sabbatical from the Université de Franche-Comté, Besançon, France where he runs a critical care and emergency department, is a member of the Board of the Medical Faculty, and a Professor of Intensive Care Medicine. His qualifications include an MD; certification as a Critical Care Physician from the Hôpital Claude Bernard, Paris; a Master of Science degree in Respiratory and Circulatory Physiology and Pathophysiology (Thesis title: Pulmonary neutrophils accumulation during peritonitis induced by cecal ligation and perforation); and a PhD (Thesis title: Pulmonary oxygen toxicity - demonstration of clinical and experimental tolerance). Professor Capellier's main research foci are Acute Respiratory Distress Syndrome (ARDS), oxygen toxicity tolerance, and ICU management of ARDS including extracorporeal membrane oxygenation (ECMO). He is also interested in ICU organisation and quality-safety in care. His experience includes a year as a Clinical Fellow and a Clinical Research Fellow at the Toronto General Hospital, Canada. Professor Capellier has published over 90 peer-reviewed papers and book chapters including in the prestigious journals JAMA and the American Journal of Respiratory and Critical Care Medicine. He has also been an invited speaker at numerous international and national conferences.
 |
Associate Professor Andrew Davies
Adjunct Associate Professor
Email
Dr Davies is a Monash Practitioner Fellow at both the School of Public Health and Preventive Medicine and The Alfred Intensive Care Unit. He is an Adjunct Associate Professor at the Department of Epidemiology and Preventive Medicine and works clinically as a Senior Intensivist at The Alfred Hospital. He leads a "Nutrition in the Critically Ill" research program at the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC) in conjunction with the Australasian Society of Parenteral and Enteral Nutrition (AuSPEN), of which he is a Past President. He is a member of the Executive of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG) and is Associate Editor of the journal Clinical Nutrition. He is a member of the Research Review Sub-Committee of The Alfred Human Research Ethics Committee and Chairman of the Ethics Committee of The Avenue Hospital. His predominant research topics include nutrition in the critically ill, mechanical ventilation, acute lung injury, severe sepsis and traumatic brain injury. He has a significant interest in clinical trial design.
 |
Associate Professor Daryl Jones BSc(Hons) MBBS FRACP FCICM MD
Adjunct Senior Research Fellow
Email
Mobile 0439 069 402
Dr Jones was the inaugural Senior Research Fellow for the ANZIC-RC. He is an Intensive Care Specialist at the Austin Hospital in Melbourne. He is interested in a number of aspects of critical care research including the Medical Emergency Team, assessment of the circulation using PiCCO and systolic pressure variation, survey research, and adrenal dysfunction in the critically ill.
 |
Associate Professor Peter Kruger MBBS BSc(Hons) FANZCA FCICM
Adjunct Senior Lecturer
Dr Kruger is the Deputy Director of Intensive Care at the Princess Alexandra Hospital in Brisbane and Associate Professor of Anaesthesia and Critical Care at the University of Queensland. He is a member of the Executive of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG) and a current examiner in both the Anaesthesia and Intensive Care college primary examinations. He has an interest in clinical and laboratory research and is the chief investigator of the NHMRC funded, CTG endorsed STATInS trial, A phase II randomised controlled trial of atorvastatin therapy in intensive care patients with severe sepsis. His research interests include drug behaviour in critically ill patients, the role of statin therapy in patients with sepsis, antibiotic therapy in critical illness and body fluid dynamics.
 |
Dr Colin McArthur BHB MBChB FANZCA FCICM
Adjunct Senior Research Fellow
Dr Colin McArthur is Clinical Director, Department of Critical Care Medicine, Auckland City Hospital; Medical Advisor - Quality & Safety, Auckland District Health Board; and Honorary Clinical Lecturer, Department of Surgery, University of Auckland. He is also the Chair of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG) and its representative on the ANZIC-RC Advisory Board. He trained in medicine in Auckland and is a Fellow of the College of Intensive Care Medicine (FCICM) and a Fellow of the Australian and New Zealand College of Anaesthetists (FANZCA). He has been an investigator in 24 investigator-initiated studies (and also 16 commercial studies) and an author of 35 publications, mostly multi-centre clinical intensive care research. Since 2001, he has been on the management and/or writing committee of eight NHMRC or HRCNZ-funded studies, five of which have been completed and published in the New England Journal of Medicine and three are on-going. He is an investigator on several current ANZIC-RC studies including the ARISE, INFINITE, EPO-TBI and POLAR studies. He was also an investigator on the ANZIC-RC's now completed STATINS study. His interests include research methodology and ethics, traumatic brain injury, sepsis, nutrition, and severe influenza.
 |
Associate Professor Cristina Morganti-Kossmann PhD
Adjunct Associate Professor
Dr Morganti-Kossmann is an Adjunct Associate Professor at the ANZIC-RC. Her qualifications include a doctoral degree in Biology from the University of Rome "la Sapienza", Department of Biochemistry and Istituto Superiore di Sanita (National Institute of Health) Rome, Italy. After completing her doctoral thesis, Dr Morganti-Kossmann undertook a postdoctoral period at the Cancer Institute Regina Elena in Rome. In 1987 she was awarded a fellowship by the Boehringer Ingelheim Fund which allowed her to work at the prestigious Institute of Neurobiology lead by Prof M Schachner at the University of Heidelberg, Germany. In 1989 she moved to the National Institutes of Health, Bethesda, USA and in 1991, Dr Morganti-Kossmann became leader of the neurotrauma research group at the University of Zurich, Switzerland where she began working on traumatic brain injury. There she investigated the role of cerebral inflammation in patients with severe head trauma, validated by mouse and rat models of focal and diffuse brain injury. This research resulted in the very first comprehensive analysis of brain inflammation in humans. In 1998 Dr Morganti-Kossmann was nominated Group Leader within the Institute of Neuroscience of Zurich established by Prof M Schwab. In 2001, she then moved to Melbourne to work at the department of Trauma Surgery of the Alfred Hospital as senior neuroscientist. Dr Morganti-Kossmann has been instrumental in expanding neurotrauma research in Melbourne including successful large collaborative program grants funded by the Transport Accident Commission (Victorian Trauma Foundation and Victorian Neurotrauma Initiative). She had a pivotal role in the establishment of the National Trauma Research Institute at the Alfred Hospital in which she was Head of Basic Research from 2004 until 2012. In 2006, Dr Morganti-Kossmann was appointed Associate Professor at Monash University and Honorary Senior Research Fellow at the Centre for Neuroscience of Melbourne University. Dr Morganti-Kossmann has served as an executive member of various scientific advisory boards (Neurosciences Victoria, AMREP, among others) and she was an advisor on basic brain trauma research during the establishment of the Victorian Neurotrauma Initiative.
 |
Professor John Myburgh MBBCh PhD FANZCA FCICM
Adjunct Associate Professor
Professor Myburgh is an Enabling Grant Chief Investigator and a foundation member and past Chair of the ANZICS Clinical Trials Group (ANZICS-CTG). He is the Director of the Division of Critical Care and Trauma at The George Institute for Global Health and Professor of Critical Care at the University of New South Wales. He holds honorary professorial appointments at the Universities of Sydney and Monash. He is a senior physician in the Department of Intensive Care Medicine at St George Hospital, Sydney. He has been involved in laboratory and clinical research since 1989. He has received over $18M in NHMRC funding, $8M in international grants, $1M in institutional grants and $8M in unrestricted commercial grants to a total of $36M since 2000. He published over 100 original articles, including 4 papers in the New England Journal of Medicine, and 20 book chapters. His research interests include catecholamine pharmacodynamics, traumatic brain injury, fluid resuscitation and endocrine homeostasis in critical illness. He has delivered over 20 plenary lectures at international meetings. Current research activities include large-scale trials of fluid resuscitation (CHEST), steroids in septic shock, glycaemic control and thermoregulation in critical illness. He has established postgraduate research programs at the George Institute for PhD and MPH students through the Universities of New South Wales and Sydney. In addition to his research activities, he has a long-standing involvement in education and is the current President of the College of Intensive Care Medicine. Within the College, he established an independent Annual Scientific Meeting in 2005 and served as a fellowship examiner for 12 years.
 |
Ms Lynette Newby MHSc(Clin Data Mgt)
Adjunct Research Fellow
Ms Newby is the Senior Research Coordinator in the Department of Critical Care Medicine and the Clinical Nurse Specialist (Multiple Sclerosis) in the Department of Neurology, Auckland City Hospital, New Zealand. She is a Management Committee Member on the ANZIC-RC's Prophylactic Hypothermia Trial to Lessen Traumatic Brain Injury (POLAR) Randomised Controlled Trial and a Monitor for the Australasian Resuscitation In Sepsis Evaluation (ARISE) Randomised Control Trial for the study's New Zealand sites. Since 1997, she has been involved in clinical research in critical care at Auckland City Hospital. Prior to that Ms Newby gained more than a decade of experience in intensive care nursing in New Zealand, the USA, Zimbabwe, Saudi Arabia, the United Kingdom, Australia and Hong Kong. Ms Newby has been an author/investigator on a number of publications, mostly multi-centre clinical intensive care research, including publications in prestigious journals such as the New England Journal of Medicine. Ms Newby is a member of the Auckland Regional Management Committee of the New Zealand Nurses Organisation - Critical Care Nurses Section (NZNO-CCNS).
 |
Associate Professor Sandra L Peake BMBS BSc(Hons) FCICM PhD
Adjunct Associate Professor
Email
Dr Peake is a Senior Intensive Care Clinician in the Department of Intensive Care Medicine at The Queen Elizabeth Hospital, Adelaide and an Associate Professor in the School of Medicine at the University of Adelaide. She is Chair of the Intensive Care Foundation Scientific Committee, Chair of the Research Committee for the Acute Care Medicine Discipline at the University of Adelaide and a member of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG) Executive Committee. She has been an examiner for the College of Intensive Care Medicine for the past 8 years. In 2000, she completed her PhD in Medicine at the University of Adelaide in the field of sepsis. Her thesis examined the role of combination anti-cytokine immunotherapy in an animal model of septic shock. Her main research interest now is large-scale, randomised clinical trials in critical care. She is currently Chair of the Management Committee for the NHMRC-funded, CTG-endorsed Australasian Resuscitation In Sepsis Evaluation (ARISE) multi-centre trial of early resuscitation in sepsis. She is also member of the Management Committee for the NHMRC-funded, CTG-endorsed multi-centre clinical trial of Early Parenteral Nutrition.
 |
Associate Professor Ville Pettilä
Adjunct Associate Professor
Dr Pettilä is an Adjunct Associate Professor with the ANZIC-RC. He was the ANZIC-RC's Senior Research Fellow in 2009. Dr Pettilä was a Chief Investigator for the INFINITE Study, and is currently involved with a number of the ANZIC-RC's studies including TRANSFUSE and EPO-TBI, and as the Principal Investigator in Finland of the ARISE-RCT Study. In Finland, Dr Pettilä is the Head of Intensive Care Units at Helsinki University Hospital and Associate Professor in Intensive Care at Helsinki University. He has published over 140 papers in peer-reviewed journals including original manuscripts in the New England Journal of Medicine, Journal of the American Medical Association, British Journal of Haematology, Stroke, Intensive Care Medicine, and Critical Care Medicine. He was a member of several European multi-centre randomised trials in critical care including as Principal Investigator for Nordic countries in the Tissue Factor Pathway Inhibitor in Severe Sepsis trial. Dr Pettilä has also contributed to the Finnish Clinical Guidelines in severe sepsis in adults and acute kidney injury. He has supervised 8 dissertations at Helsinki University with topics including "APRV", "Acute renal failure in critically ill patients", "Severe sepsis in Finnish ICUs", "Hemodynamics and outcome in septic shock", and "Biomarkers in acute respiratory failure".
 |
Associate Professor David Pilcher
Adjunct Clinical Associate Professor
Dr Pilcher has worked as an Intensive Care Specialist at The Alfred Hospital in Melbourne since 2006. He trained in respiratory and general medicine in the United Kingdom before coming to Australia to complete his Intensive Care fellowship in 2002. Dr Pilcher is Director of the ANZICS Adult Patient Database and Chair of the Australian and New Zealand Intensive Care Society Centre for Outcome and Resource Evaluation (ANZICS-CORE). He holds an Intensive Care Practitioner fellowship with Monash University. His research interests include organ donation, lung transplantation and the epidemiology of intensive care unit outcomes.
 |
Associate Professor Jeff Presneill MBBS PhD MBiostat PGDipEcho FRACP FCICM
Adjunct Associate Professor
Dr Presneill is Deputy Director and Director of Research, Campus Wide Adult ICU, Mater Health Services, Brisbane. He is an Associate Professor at the University of Queensland and Adjunct Associate Professor at Monash University. Dr Presneill trained in respiratory medicine and intensive care then completed a doctoral thesis on aspects of the human immune response in severe sepsis and septic shock. Dr Presneill also undertook training in biostatistics and is an enthusiastic supporter of the Biostatistics Collaboration of Australia. He is involved in several large clinical studies through the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), and is the current Queensland representative to the ANZICS Clinical Trials Group and the ANZICS Safety and Quality Committee.
 |
Professor Michael Reade MBBS BSc MPH DPhil DMCC DIMCRC SEd PGCertAME FCCP FANZCA FCICM
Adjunct Professor
Professor Reade became the inaugural Australian Defence Force (ADF) Professor and Chair of Military Medicine and Surgery at the University of Queensland in 2011. An anaesthetist and intensivist, he also holds a clinical appointment at the Royal Brisbane and Women's Hospital and a military appointment at the ADF Joint Health Command. He has >60 publications across the breadth of intensive care research, from applied molecular biology to statistical methodology and clinical trials, and brings together expertise in military and civilian clinical care and research. He is one of few intensivists with postgraduate qualifications in both basic science (doctorate University of Oxford) and statistics / epidemiology (MPH University of Pittsburgh). Prof Reade has held faculty appointments at University of Oxford, University of Pittsburgh, and University of Melbourne. He has established collaborations with military medical research groups in the UK and USA looking at trauma systems design and novel therapies for blast injury and exsanguinating haemorrhage. He is a chief investigator on an $830K NHMRC project grant investigating the renal effects of protein in critical illness, and a management committee member in a further two NHMRC supported trials totalling $3.7M. Prof Reade was the youngest ever officer to win the Prince of Wales Award, which led to his being the first foreign officer to command US regular soldiers at the US National Training Center. He has deployed to Bosnia and Kosovo (on attachment to the British Airborne Brigade) and to East Timor and the Solomon Islands. In 2009 he was the clinical director of the NATO hospital, Tarin Kot, Afghanistan. Until mid-2011 he commanded the Victorian medical specialists of the 3rd Health Support Battalion. He is currently a Lieutenant Colonel posted to Joint Health Command in Canberra.
 |
Dr Ian Seppelt MBBS BMedSc FANZCA FCICM
Adjunct Senior Research Fellow
Dr Seppelt is a Senior Staff Specialist in the Department of Intensive Care Medicine, Nepean Hospital and Sydney Medical School, University of Sydney; Honorary Senior Research Fellow, The George Institute for International Health, Sydney; and Advanced Scholar and Clinical Senior Lecturer, Australian School of Advanced Medicine, Macquarie University. He is a Board Member and Secretary of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG). He is a Management Committee member of the ANZIC-RC's INFINITE and SPICE studies, the Bacteraemic Load in Septic Shock (BLISS) study through the NHMRC CCRE in Critical Infection, and the ANZICS-CTG Point Prevalence Program. He is the ANZ lead for the international Selective Decontamination of the Digest Tract (SuDDICU) research program. Dr Seppelt's research interests include clinical research ethics, the clinical management of severe sepsis, neurotrauma, intensive care sedation and echocardiography in intensive care. He is a part owner of a very nice vineyard and is professional horse transport technician for his children.
 |
Associate Professor Yahya Shehabi MBBS FCICM FANZCA EMBA GAICD
Adjunct Associate Professor
Dr Shehabi is the Medical Director of the Acute Complex and Community Care Clinical Services Program (Critical Care, Cardiovascular Medicine and Surgery, Institute of Neurosciences, Spinal Medicine, General Rehabilitation, Aged Care and Community Health) at Prince of Wales Hospital; the Director of Intensive Care Research, at Prince of Wales Hospital, Sydney; and Associate Professor in the School of Medicine at University New South Wales. Since 2009, Dr Shehabi has been involved with the ANZIC-RC at Monash University as a Principal Investigator at the Prince of Wales Hospital, Sydney, for the NHMRC-funded ARISE randomised controlled trial (RCT). Dr Shehabi was the Chief Investigator on the ANZIC-RC's sedation studies: Australian and New Zealand Sedation Practice in Intensive Care (ANZ SPICE), a multicentre longitudinal cohort study; Malaysian Sedation Practice in Intensive Care (My SPICE), a multicentre longitudinal cohort study in Malaysia; and Sedation Practice in Intensive Care (ANZ SPICE) pilot study, a research program endorsed by the Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group as a multicentre pilot RCT into the effect of Early Goal Directed Sedation versus Conventional Sedation. His qualifications include an MBBS; Master of Executive Business Administration (EMBA); and a Graduate Diploma of the Australian Institute of Company Directors (GAICD). Dr Shehabi was a Foundation Fellow of the Joint Faculty of Intensive Care Medicine (JFICM) and the College of Intensive Care Medicine (FCICM). He is a Fellow of the Australian and New Zealand College of Anaesthetists (FANZCA). He has been a Chief Investigator on many multicentre trials and a Principal Investigator on five additional studies including studies on Procalcitonin guided antibiotic rational decision making in the ICU, early parenteral nutrition in the ICU, sedation and delirium in the ICU, and biomarker profile as predictors of outcome after high risk cardiac surgery. Dr Shehabi has published over 30 peer-reviewed papers and book chapters. His most significant publication is the SEDCOM study published in JAMA in 2009. Dr Shehabi was Chair of the Practice and Economics Committee of the ANZICS from 2004 to 2010, Director of the ANZICS Board for 6 years, and is the current Chair of the Intensive Care Foundation of ANZ.
 |
Mr Mick Stephenson
Adjunct Research Fellow
Mr Mick Stephenson is Regional Manager and MICA Paramedic with Ambulance Victoria (AV) and a Sessional Lecturer at Monash University to MICA paramedic and AAV students. He is also a current Board Member (Director) and Committee Chair of the Emergency Services and State Superannuation Fund. Since 1996, he has worked for Ambulance Victoria with responsibilities including management of all aspects of ambulance in Gippsland , AV liaison role for major clinical trials of international significance; delivery of MICA road ambulance response for the Melbourne Metropolitan region; management of industrial relations issues for the MICA group and AV generally; serving on key AV committees such as Medical Advisory Committee, AV Board of Studies and the Credentialing Committee; provision of reports on MICA status and activity for the CEO, Committee of Management and Government; and to develop relationships and mentoring processes for rural MICA Team Managers with the metropolitan MICA Team Managers. Mr Stephenson has qualifications in emergency medicine and intensive care nursing. Mr Stephenson is a Management Committee Member on the ANZIC-RC's POLAR-RCT (Prophylactic Hypothermia Trial to Lessen Traumatic Brain Injury - Randomised Controlled Trial).
 |
Ms Shirley Vallance
Adjunct Research Fellow
Ms Shirley Vallance is Clinical Research Manager, Intensive Care, The Alfred Hospital. As an Investigator and/or Management Committee Member on several current ANZIC-RC studies including the EPO-TBI, PHARLAP and TRANSFUSE studies, Ms Vallance has had a long and productive collaboration with the ANZIC-RC. Since 2001, she has been involved in clinical research in intensive care at The Alfred Hospital, and prior to that was the Research Officer on the Consultative Committee on Road Traffic Fatalities, Victorian Institute Forensic Medicine. Ms Vallance also has training and experience in intensive care nursing. Ms Vallance is an author on 9 publications, mostly multi-centre clinical intensive care research, including publications in prestigious journals such as the New England Journal of Medicine. She was an investigator on 12 additional publications. Ms Vallance was an invited speaker at conferences including the International Neurotrauma Symposium in Rotterdam, The Netherlands. She is a reviewer of endorsement applications for the Australian and New Zealand Intensive Care Clinical Trials Group (ANZICS-CTG). Ms Vallance is a member of the Australian and New Zealand Intensive Care Society (ANZICS), the Australian and New Zealand Forensic Science Society and the Women in Neurotrauma Research Association.
 |
Professor Steven Webb MBBS PhD MPH FRACP FCICM
Adjunct Professor
Professor Steve Webb is a Senior Staff Specialist in Intensive Care Medicine at Royal Perth Hospital and a Clinical Professor in the School of Medicine and Pharmacology and the School of Population Health at the University of Western Australia. Professor Webb is the immediate past Chair of the Australian and New Zealand Intensive Care Society Clinical Trials Group which, in its 14 year history, has received more than $40 million in research funding, randomised more than 19,000 patients in clinical trials, and published more than 60 manuscripts. He is a grant holder for over $15 million of research funding, more than half of which is as a Chief Investigator on NHMRC Project Grants and a Centre for Research Excellence Grant. He has published over 70 manuscripts in peer-reviewed journals including manuscripts in The New England Journal of Medicine, Journal of the American Medical Association and the British Medical Journal. He chairs the Human Research Ethics Committee at the University of Western Australia. His clinical research interests include the long-term consequences of and recovery after critical illness, resuscitation and treatment of patients with septic shock, management of traumatic brain injury, pathogenesis of septic shock, antimicrobial therapy, acute kidney injury, and choice of intravenous fluids in critically ill patients. He is the Chair of the Australian and New Zealand Intensive Care Influenza Investigators and a member of the management committee of several multicentre international randomised controlled trials including ARISE (an RCT of early goal directed therapy in severe sepsis), CHEST (an RCT of hyroxyethyl starch compared with normal saline in patients admitted to an ICU), and POLAR (an RCT of early hypothermia for severe traumatic brain injury).
 |
Ms Patricia Williams RGN BNP (Int Care)
Adjunct Research Fellow
Ms Tricia Williams is a Donation Specialist - Nursing Coordinator at DonateLife South Australila. Previously she was the Research Project Nurse and Blood Gas Laboratory Manager, Department of Intensive Care Medicine at The Queen Elizabeth Hospital (TQEH), South Australia, and Affiliate Lecturer in the Discipline of Acute Care, School of Medicine, Faculty of Health Science at the University of Adelaide. Ms Williams was an Investigator and/or Management Committee Member on several ANZIC-RC studies including the ARISE randomised controlled trial and the ARISE health economic evaluation, STATINS, INFINITE and Fresh Blood studies. Ms Williams's qualifications include a Bachelor of Nursing Practice and several advanced courses in critical care nursing, and she is also a Registered Nurse. Since 1997, she has been involved in clinical research in intensive care at TQEH, initially as a Clinical Research Nurse, and since 2006 as the Research Project Nurse and Blood Gas Laboratory Manager. During that time, Ms Williams has been an Investigator on 38 research studies. Ms Williams has been an author/investigator on a number of publications, mostly multi-centre clinical intensive care research, including publications in Anaesthesia and Intensive Care. She was an invited presenter at the Australian and New Zealand Intensive Care Clinical Trials Group (ANZICS-CTG) Annual Scientific Meeting in 2010 and 2011. Ms Williams is an Executive Committee Member of the Intensive Care Research Coordinators Interest Group (IRCIG), and is also a member of the ANZICS-CTG and the Royal Australian Nursing Federation.
